Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McGill University

$27,000.00

Using Machine Learning to Design Protein-Based Antimicrobials

FY 2025-26

Summary
Severe gum disease, or periodontitis, is the leading cause of adult tooth loss and one of the most common chronic diseases worldwide. In 2025, the World Health Organization estimates that it affects over one billion people. A major contributor to this disease is the bacterium Porphyromonas gingivalis, which, in addition to periodontitis, is linked to other serious conditions such as heart disease, diabetes, and Alzheimer’s disease. Current treatments against P. gingivalis rely mainly on physical plaque removal and antibiotics, which indiscriminately remove good bacteria and contribute to antibiotic resistance. To initiate infection, the bacterium uses tiny hair-like appendages called fimbriae to attach to tissue inside the mouth, interfere with the immune system, and invade host cells. Because fimbriae are essential for initial infection, virulence, and sit exposed on the bacterial surface they are excellent targets for new therapies. Advances in artificial intelligence (AI), such as AlphaFold, now make it possible to design proteins with molecular shapes tailored to bind biological targets with remarkable accuracy. I am leveraging these advances to create new therapeutic proteins that block P. gingivalis fimbriae, interfering with its ability to gain and maintain a foothold in the oral cavity. Thousands of candidates will be generated and screened, first computationally and then experimentally, to identify those that most effectively prevent fimbrial assembly or function. By creating a targeted, microbiome-friendly therapy that interferes with a function critical to P. gingivalis pathogenicity, this work has the potential to transform how we treat gum disease, reduce reliance on antibiotics, and serve as one of the first examples of AI-guided drug development.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573329
Name
Tran Nhat A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using Machine Learning to Design Protein-Based Antimicrobials
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Adhesins; Antivirulence; Cryo-Em; De Novo Protein Binder Design; Fimbriae; Periodontitis; Porphyromonas Gingivalis; Protein Engineering; Structural Biology; Structure-Based Drug Design
Abstract
Severe gum disease, or periodontitis, is the leading cause of adult tooth loss and one of the most common chronic diseases worldwide. In 2025, the World Health Organization estimates that it affects over one billion people. A major contributor to this disease is the bacterium Porphyromonas gingivalis, which, in addition to periodontitis, is linked to other serious conditions such as heart disease, diabetes, and Alzheimer’s disease. Current treatments against P. gingivalis rely mainly on physical plaque removal and antibiotics, which indiscriminately remove good bacteria and contribute to antibiotic resistance. To initiate infection, the bacterium uses tiny hair-like appendages called fimbriae to attach to tissue inside the mouth, interfere with the immune system, and invade host cells. Because fimbriae are essential for initial infection, virulence, and sit exposed on the bacterial surface they are excellent targets for new therapies. Advances in artificial intelligence (AI), such as AlphaFold, now make it possible to design proteins with molecular shapes tailored to bind biological targets with remarkable accuracy. I am leveraging these advances to create new therapeutic proteins that block P. gingivalis fimbriae, interfering with its ability to gain and maintain a foothold in the oral cavity. Thousands of candidates will be generated and screened, first computationally and then experimentally, to identify those that most effectively prevent fimbrial assembly or function. By creating a targeted, microbiome-friendly therapy that interferes with a function critical to P. gingivalis pathogenicity, this work has the potential to transform how we treat gum disease, reduce reliance on antibiotics, and serve as one of the first examples of AI-guided drug development.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tran, Nhat A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~